Insider Selling: Kewaunee Scientific (NASDAQ:KEQU) CEO Sells 773 Shares of Stock

Key Points

• Thomas David Hull III, CEO of Kewaunee Scientific, sold 773 shares of the company for approximately $35,048, reducing his ownership by 1.75% to 43,294 shares valued at about $1.96 million.
• Kewaunee Scientific stock recently increased 1.3% to trade at $44.60, amid ongoing institutional investment interest, with hedge funds holding 32.69% of the company's stock.
• Wall Street analysts have upgraded Kewaunee Scientific's rating from "hold" to "buy", reflecting positive expectations for the company's growth trajectory.

Kewaunee Scientific Corporation (NASDAQ:KEQU - Get Free Report) CEO Thomas David Hull III sold 773 shares of Kewaunee Scientific stock in a transaction on Friday, September 19th. The shares were sold at an average price of $45.34, for a total transaction of $35,047.82. Following the completion of the transaction, the chief executive officer owned 43,294 shares in the company, valued at approximately $1,962,949.96. This represents a 1.75% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Thomas David Hull III also recently made the following trade(s):

• On Thursday, September 18th, Thomas David Hull III sold 652 shares of Kewaunee Scientific stock. The shares were sold at an average price of $46.00, for a total value of $29,992.00.

Kewaunee Scientific Stock Performance

Shares of NASDAQ:KEQU traded down $0.01 during trading on Monday, reaching $44.00. The company had a trading volume of 4,425 shares, compared to its average volume of 14,942. The firm has a market capitalization of $126.28 million, a price-to-earnings ratio of 10.65 and a beta of 0.75. The company has a debt-to-equity ratio of 0.88, a current ratio of 2.32 and a quick ratio of 1.63. The stock's fifty day moving average price is $54.22 and its 200 day moving average price is $45.51. Kewaunee Scientific Corporation has a fifty-two week low of $30.33 and a fifty-two week high of $71.33.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last released its earnings results on Wednesday, September 10th. The technology company reported $1.10 earnings per share (EPS) for the quarter. The business had revenue of $71.10 million for the quarter. Kewaunee Scientific had a return on equity of 25.65% and a net margin of 4.68%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Minerva Advisors LLC grew its holdings in Kewaunee Scientific by 5.0% during the second quarter. Minerva Advisors LLC now owns 77,442 shares of the technology company's stock worth $4,501,000 after acquiring an additional 3,677 shares during the period. American Century Companies Inc. grew its holdings in Kewaunee Scientific by 12.5% during the second quarter. American Century Companies Inc. now owns 55,310 shares of the technology company's stock worth $3,247,000 after acquiring an additional 6,128 shares during the period. De Lisle Partners LLP grew its holdings in Kewaunee Scientific by 6.7% during the second quarter. De Lisle Partners LLP now owns 47,977 shares of the technology company's stock worth $2,811,000 after acquiring an additional 3,029 shares during the period. Geode Capital Management LLC grew its holdings in Kewaunee Scientific by 0.9% during the second quarter. Geode Capital Management LLC now owns 24,013 shares of the technology company's stock worth $1,410,000 after acquiring an additional 223 shares during the period. Finally, Punch & Associates Investment Management Inc. acquired a new position in Kewaunee Scientific during the first quarter worth $788,000. Institutional investors and hedge funds own 32.69% of the company's stock.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised Kewaunee Scientific from a "hold" rating to a "buy" rating in a report on Saturday, July 5th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.